Skip to main content

Publications

featured publications

  • Acquisition, image quality, and PI-RADS agreement of ultrahigh-gradient DWI in prostate 3-T MRI.

    European radiology experimental

    Authors: Leon M Bischoff, Christoph Endler, Philipp Krausewitz, Joerg Ellinger, Niklas Klümper, Alexander Isaak, Narine Mesropyan, Dmitrij Kravchenko, Daniel Kuetting, Alois M Sprinkart, Petra Mürtz, Claus C Pieper, Julian A Luetkens

  • Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma.

    European urology open science

    Authors: Richard Weiten, Constantin Rieger, Julian Heidenreich, Yuri Tolkach, Thomas Stehle, Florian Schmid, Teresa Schmidt, Martin Glas, Tobias Blau, Kathy Keyvani, Thomas Büttner, Viktor Grünwald, Michael Hölzel, Axel Heidenreich, Markus Eckstein, Niklas Klümper

  • [From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma].

    Urologie (Heidelberg, Germany)

    Authors: Günter Niegisch, Stefanie Zschäbitz, Markus Eckstein, Niklas Klümper

  • Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response.

    Journal for immunotherapy of cancer

    Authors: Daniel Navarro-Garcia, Francesco Grussu, Christina Zatse, Niklas Klümper, Carlos Macarro, Alberto Hernando-Calvo, Marta Sanz, Maria Vieito, Irene Braña, Oriol Mirallas, Guzmán Alonso, Vladimir Galvao, Giulia Pretelli, Julia Lostes, Arjun Oberoi, Rodrigo Toledo, Paolo Nuciforo, Elena Garralda, Raquel Perez-Lopez

  • [Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making].

    Aktuelle Urologie

    Authors: Fabienne Lange, Nadine Therese Gaisa, Christian Bolenz, Niklas Klümper, Florian Roghmann, Markus Eckstein

  • Can NaCl predict or even enhance responses to immunotherapy in cancer?

    European journal of cancer (Oxford, England : 1990)

    Authors: Jonas Saal, Michael Hölzel, Niklas Klümper

  • On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.

    Frontiers in immunology

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Annkristin Heine, Katjana Schwab, Peter Brossart, Niklas Klümper, Jonas Saal

  • TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

    World journal of urology

    Authors: Carolina Kessler, Melanie von Brandenstein, Niklas Klümper, Philipp Krausewitz, Enno Storz, Constantin Rieger, Laurenz Sperber, Pia Paffenholz, Yuri Tolkach, Ralph Wirtz, Markus Eckstein, Axel Heidenreich, Richard Weiten

  • NaCl and urea modulate CD8+ T cell survival, renal accumulation and response to BK virus.

    JCI insight

    Authors: Peyman Falahat, Adrian Goldspink, Lucia Oehler, Jessica Schmitz, Julia Miranda, Islem Gammoudi, Jan Hinrich Bräsen, Niklas Klümper, Olena Babyak, Christian Kurts, Herrmann Haller, Marieta Toma, Sibylle von Vietinghoff

  • AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer.

    Nature communications

    Authors: Pierre-Antoine Bannier, Charlie Saillard, Philipp Mann, Maxime Touzot, Charles Maussion, Christian Matek, Niklas Klümper, Johannes Breyer, Ralph Wirtz, Danijel Sikic, Bernd Schmitz-Dräger, Bernd Wullich, Arndt Hartmann, Sebastian Försch, Markus Eckstein